{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:29:37Z","timestamp":1780525777324,"version":"3.54.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R03AG063255"],"award-info":[{"award-number":["R03AG063255"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG054156"],"award-info":[{"award-number":["RF1AG054156"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01-CX001038"],"award-info":[{"award-number":["I01-CX001038"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["(#681712"],"award-info":[{"award-number":["(#681712"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["#2017-00915"],"award-info":[{"award-number":["#2017-00915"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["#2018-02532"],"award-info":[{"award-number":["#2018-02532"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Neurofilament light chain (NfL) is a promising biomarker of neurodegeneration in the cerebrospinal fluid and blood. This study investigated the presence of NfL in the vitreous humor and its associations with amyloid beta, tau, inflammatory cytokines and vascular proteins, apolipoprotein E (<jats:italic>APOE<\/jats:italic>) genotypes, Mini-Mental State Examination (MMSE) scores, systemic disease, and ophthalmic diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a single-site, prospective, cross-sectional cohort study. Undiluted vitreous fluid (0.5\u20131.0\u2009mL) was aspirated during vitrectomy, and whole blood was drawn for APOE genotyping. NfL, amyloid beta (A\u03b2), total Tau (t-Tau), phosphorylated Tau (p-Tau181), inflammatory cytokines, chemokines, and vascular proteins in the vitreous were quantitatively measured by immunoassay. The main outcome measures were the detection of NfL levels in the vitreous humor and its associations with the aforementioned proteins. Linear regression was used to test the associations of NfL with other proteins,<jats:italic>APOE<\/jats:italic>genotypes, MMSE scores, and ophthalmic and systemic diseases after adjustment for age, sex, education level, and other eye diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>NfL was detected in all 77 vitreous samples. NfL was not found to be associated with ophthalmic conditions, APOE genotypes, MMSE scores, or systemic disease (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). NfL levels were positively associated with increased vitreous levels of A\u03b2<jats:sub>40<\/jats:sub>(<jats:italic>p<\/jats:italic>\u2009=\u20097.7\u2009\u00d7\u200910<jats:sup>\u22125<\/jats:sup>), A\u03b2<jats:sub>42<\/jats:sub>(<jats:italic>p<\/jats:italic>\u2009=\u20092.8\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>), and t-tau (<jats:italic>p<\/jats:italic>\u2009=\u20095.5\u2009\u00d7\u200910<jats:sup>\u22127<\/jats:sup>), but not with p-tau181 (<jats:italic>p<\/jats:italic>\u2009=\u20090.53). NfL also had significant associations with inflammatory cytokines such as interleukin-15 (IL-15,<jats:italic>p<\/jats:italic>\u2009=\u20095.3\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>), IL-16 (<jats:italic>p<\/jats:italic>\u2009=\u20092.2\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>), monocyte chemoattractant protein-1 (MCP1,<jats:italic>p<\/jats:italic>\u2009=\u20094.1\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>), and vascular proteins such as vascular endothelial growth factor receptor-1 (VEGFR1,<jats:italic>p<\/jats:italic>\u2009=\u20092.9\u2009\u00d7\u200910<jats:sup>\u22126<\/jats:sup>), Vegf-C (<jats:italic>p<\/jats:italic>\u2009=\u20098.6\u2009\u00d7\u200910<jats:sup>\u22126<\/jats:sup>), vascular cell adhesion molecule-1 (VCAM-1,<jats:italic>p<\/jats:italic>\u2009=\u20095.0\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>), Tie-2 (<jats:italic>p<\/jats:italic>\u2009=\u20096.3\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>), and intracellular adhesion molecular-1 (ICAM-1,<jats:italic>p<\/jats:italic>\u2009=\u20091.6\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NfL is detectable in the vitreous humor of the eye and significantly associated with amyloid beta, t-tau, and select inflammatory and vascular proteins in the vitreous. Additionally, NfL was not associated with patients\u2019 clinical eye condition. Our results serve as a foundation for further investigation of NfL in the ocular fluids to inform us about the potential utility of its presence in the eye.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13195-020-00677-4","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T15:11:58Z","timestamp":1600355518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neurofilament light chain in the vitreous humor of the eye"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0061-098X","authenticated-orcid":false,"given":"Manju L.","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viha","family":"Vig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyoon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa G.","family":"Fiorello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole H.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyungah R.","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"issue":"10","key":"677_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbr M, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565\u201381. https:\/\/doi.org\/10.1038\/s41582-019-0244-7.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"677_CR2","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen MG, Kim MO, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2018;10(4):a033118. Published 2018 Apr 2. https:\/\/doi.org\/10.1101\/cshperspect.a033118.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8","key":"677_CR3","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):870\u201381. https:\/\/doi.org\/10.1136\/jnnp-2018-320106.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"677_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ana.24954","volume":"81","author":"G Disanto","year":"2017","unstructured":"Disanto G, Barro C, Benkert P, et al. Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann Neurol. 2017;81(6):857\u201370. https:\/\/doi.org\/10.1002\/ana.24954.","journal-title":"Ann Neurol"},{"key":"677_CR5","doi-asserted-by":"publisher","unstructured":"Olsson B, Portelius E, Cullen NC, et al. Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders. JAMA Neurol. 76(3):318\u201325. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3746.","DOI":"10.1001\/jamaneurol.2018.3746"},{"issue":"2","key":"677_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","volume":"25","author":"O Preische","year":"2019","unstructured":"Preische O, Schultz SA, Apel A, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease. Nat Med. 2019;25(2):277\u201383. https:\/\/doi.org\/10.1038\/s41591-018-0304-3.","journal-title":"Nat Med"},{"issue":"5","key":"677_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K, Alzheimer\u2019s Disease Neuroimaging Initiative. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2017;74(5):557\u201366. https:\/\/doi.org\/10.1001\/jamaneurol.2016.6117.","journal-title":"JAMA Neurol"},{"key":"677_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.neuint.2017.05.010","volume":"108","author":"S Lista","year":"2017","unstructured":"Lista S, Toschi N, Baldacci F, et al. Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer\u2019s disease. Neurochem Int. 2017;108:355\u201360. https:\/\/doi.org\/10.1016\/j.neuint.2017.05.010.","journal-title":"Neurochem Int"},{"issue":"1","key":"677_CR9","doi-asserted-by":"publisher","first-page":"17368","DOI":"10.1038\/s41598-018-35766-w","volume":"8","author":"Y Lin","year":"2019","unstructured":"Lin Y, Lee W, Wang S, et al. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease. Sci Rep. 2019;8(1):17368. https:\/\/doi.org\/10.1038\/s41598-018-35766-w.","journal-title":"Sci Rep"},{"issue":"Suppl 3","key":"677_CR10","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.21037\/atm.2019.05.81","volume":"7","author":"F Massa","year":"2019","unstructured":"Massa F, Meli R, Morbelli S, Nobili F, Pardini M. Serum neurofilament light chain rate of change in Alzheimer\u2019s disease: potentials applications and notes of caution. Ann Transl Med. 2019;7(Suppl 3):S133. https:\/\/doi.org\/10.21037\/atm.2019.05.81.","journal-title":"Ann Transl Med"},{"issue":"2","key":"677_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1350-9462(00)00024-0","volume":"20","author":"E Sernagor","year":"2010","unstructured":"Sernagor E, Eglen SJ, Wong ROL. Development of retinal ganglion cell structure and function. Prog Retin Eye Res. 2010;20(2):139\u201374. https:\/\/doi.org\/10.1016\/S1350-9462(00)00024-0.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"677_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/01.STR.0000195134.04355.e5","volume":"37","author":"LS Cooper","year":"2006","unstructured":"Cooper LS, Wong TY, Klein R, Sharrett AR, Bryan RN, Hubbard LD, Couper DJ, Heiss G, Sorlie PD. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke. 2006;37(1):82\u20136. https:\/\/doi.org\/10.1161\/01.STR.0000195134.04355.e5.","journal-title":"Stroke"},{"issue":"1","key":"677_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11060-010-0303-9","volume":"102","author":"JT Hong","year":"2011","unstructured":"Hong JT, Chae JB, Lee JY, et al. Ocular involvement in patients with primary CNS lymphoma. J Neurooncol. 2011;102(1):139\u201345. https:\/\/doi.org\/10.1007\/s11060-010-0303-9.","journal-title":"J Neurooncol"},{"issue":"3","key":"677_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/09273940903108544","volume":"17","author":"HN Sen","year":"2009","unstructured":"Sen HN, Bodaghi B, Hoang PL, Nussenblatt R. Primary intraocular lymphoma: diagnosis and differential diagnosis. Ocul Immunol Inflamm. 2009;17(3):133\u201341. https:\/\/doi.org\/10.1080\/09273940903108544.","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"677_CR15","first-page":"697","volume":"17","author":"MY Yen","year":"1985","unstructured":"Yen MY, Lui JH. Malignant lymphoma involving the optic nerve head and the retina. Ann Ophthalmol. 1985;17(11):697\u2013700.","journal-title":"Ann Ophthalmol"},{"issue":"8","key":"677_CR16","first-page":"2043","volume":"26","author":"T Hirai","year":"2005","unstructured":"Hirai T, Ando Y, Yamura M, et al. Transthyretin-related familial amyloid polyneuropathy: evaluation of CSF enhancement on serial T1-weighted and fluid-attenuated inversion recovery images following intravenous contrast administration. Am J Neuroradiol. 2005;26(8):2043\u20138.","journal-title":"Am J Neuroradiol"},{"issue":"3","key":"677_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3928\/0191-3913-19860501-06","volume":"23","author":"PA Lamba","year":"1986","unstructured":"Lamba PA, Bhalla JS, Mullick DN. Ocular manifestations of tubercular meningitis: a clinic-biochemical study. J Pediatr Ophthalmol Strabismus. 1986;23(3):123\u20135.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"677_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuro.2017.03.006","volume":"61","author":"M Hersi","year":"2107","unstructured":"Hersi M, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D. Risk factors associated with onset and progression of Alzheimer\u2019s disease: a systematic review of the evidence. Neurotoxicology. 2107;61:143\u201387. https:\/\/doi.org\/10.1016\/j.neuro.2017.03.006.","journal-title":"Neurotoxicology"},{"key":"677_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","volume":"124","author":"J Zhang","year":"2017","unstructured":"Zhang J, Chen C, Hua S, Liao H, Wang M, Xiong Y, Cao F. An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer\u2019s disease. Diabetes Res Clin Pract. 2017;124:41\u20137. https:\/\/doi.org\/10.1016\/j.diabres.2016.10.024.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"677_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jalz.2018.06.2856","volume":"15","author":"CS Lee","year":"2019","unstructured":"Lee CS, Larson EB, Gibbons LE, et al. Associations between recent and established ophthalmic conditions and risk of Alzheimer\u2019s disease. Alzheimers Dement. 2019;15(1):34\u201341. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.2856.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"677_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2174\/1570159X16666171206144045","volume":"16","author":"R Mancino","year":"2018","unstructured":"Mancino R, Martucci A, Cesareo M, et al. Glaucoma and Alzheimer disease: one age-related neurodegenerative disease of the brain. Curr Neuropharmacol. 2018;16(7):971\u20137. https:\/\/doi.org\/10.2174\/1570159X16666171206144045.","journal-title":"Curr Neuropharmacol"},{"key":"677_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2741\/e794","volume":"9","author":"L Biscetti","year":"2017","unstructured":"Biscetti L, Luchetti E, Vergaro A, Menduno P, Cagini C, Parnetti L. Associations of Alzheimer\u2019s disease with macular degeneration. Front Biosci. 2017;9:174\u201391. https:\/\/doi.org\/10.2741\/e794.","journal-title":"Front Biosci"},{"key":"677_CR23","doi-asserted-by":"publisher","unstructured":"Ohno-Matsui K, Akiba M, Moriyama M, Ishibashi T, Tokoro T, Spaide R. Imaging retrobulbar subarachnoid space around optic nerve by swept-source optical coherence tomography in eyes with pathologic myopia. Invest Ophthalmol Vis Sci. 52(13):9644\u201350. https:\/\/doi.org\/10.1167\/iovs.11-8597.","DOI":"10.1167\/iovs.11-8597"},{"issue":"4","key":"677_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3233\/JAD-181104","volume":"68","author":"LM Wright","year":"2019","unstructured":"Wright LM, Stein TD, Jun G, et al. Association of cognitive function with amyloid-\u03b2 and tau proteins in the vitreous humor. J Alzheimers Dis. 2019;68(4):1429\u201338. https:\/\/doi.org\/10.3233\/JAD-181104.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"677_CR25","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10072-014-2055-3","volume":"36","author":"EO Oktem","year":"2015","unstructured":"Oktem EO, Derle E, Kibaroglu S, Oktem C, Akkoyun I, Can U. The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci. 2015;36(7):1141\u20136. https:\/\/doi.org\/10.1007\/s10072-014-2055-3.","journal-title":"Neurol Sci"},{"issue":"1","key":"677_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-141659","volume":"45","author":"CY Cheung","year":"2015","unstructured":"Cheung CY, Ong YT, Hilal S, et al. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2015;45(1):45\u201356. https:\/\/doi.org\/10.3233\/JAD-141659.","journal-title":"J Alzheimers Dis"},{"key":"677_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","volume":"6","author":"J den Haan","year":"2017","unstructured":"den Haan J, Verbraak FD, Visser PJ, Bouwman FH. Retinal thickness in Alzheimer\u2019s disease: a systematic review and meta-analysis. Alzheimers Dement (Amst). 2017;6:162\u201370. Published 2017 Jan 25. https:\/\/doi.org\/10.1016\/j.dadm.2016.12.014.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"677_CR28","doi-asserted-by":"publisher","first-page":"e0153830","DOI":"10.1371\/journal.pone.0153830","volume":"11","author":"LP Cunha","year":"2016","unstructured":"Cunha LP, Lopes LC, Costa-Cunha LV, et al. Macular thickness measurements with frequency domain-OCT for quantification of retinal neural loss and its correlation with cognitive impairment in Alzheimer\u2019s disease. PLoS One. 2016;11(4):e0153830. Published 2016 Apr 22. https:\/\/doi.org\/10.1371\/journal.pone.0153830.","journal-title":"PLoS One"},{"issue":"5","key":"677_CR29","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ophtha.2013.12.023","volume":"121","author":"ES Garcia-Martin","year":"2014","unstructured":"Garcia-Martin ES, Rojas B, Ramirez AI, et al. Macular thickness as a potential biomarker of mild Alzheimer\u2019s disease. Ophthalmology. 2014;121(5):1149\u201351. https:\/\/doi.org\/10.1016\/j.ophtha.2013.12.023.","journal-title":"Ophthalmology"},{"key":"677_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.dadm.2017.10.005","volume":"10","author":"J den Haan","year":"2017","unstructured":"den Haan J, Janssen SF, van de Kreeke JA, Scheltens P, Verbraak FD, Bouwman FH. Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer\u2019s disease and controls. Alzheimers Dement (Amst). 2017;10:49\u201355. Published 2017 Nov 6. https:\/\/doi.org\/10.1016\/j.dadm.2017.10.005.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"6","key":"677_CR31","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1111\/aos.12977","volume":"94","author":"E Garcia-Martin","year":"2016","unstructured":"Garcia-Martin E, Bambo MP, Marques ML, et al. Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer\u2019s disease. Acta Ophthalmol. 2016;94(6):e454\u20139. https:\/\/doi.org\/10.1111\/aos.12977.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"677_CR32","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00417-017-3715-9","volume":"255","author":"JP Cunha","year":"2017","unstructured":"Cunha JP, Proen\u00e7a R, Dias-Santos A, et al. OCT in Alzheimer\u2019s disease: thinning of the RNFL and superior hemiretina. Graefes Arch Clin Exp Ophthalmol. 2017;255(9):1827\u201335. https:\/\/doi.org\/10.1007\/s00417-017-3715-9.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"677_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3341\/kjo.2016.0118","volume":"31","author":"JY Kwon","year":"2017","unstructured":"Kwon JY, Yang JH, Han JS, Kim DG. Analysis of the retinal nerve fiber layer thickness in Alzheimer disease and mild cognitive impairment. Korean J Ophthalmol. 2017;31(6):548\u201356. https:\/\/doi.org\/10.3341\/kjo.2016.0118.","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"677_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-160067","volume":"54","author":"S Liu","year":"2016","unstructured":"Liu S, Ong YT, Hilal S, et al. The association between retinal neuronal layer and brain structure is disrupted in patients with cognitive impairment and Alzheimer\u2019 disease. J Alzheimers Dis. 2016;54(2):585\u201395. https:\/\/doi.org\/10.3233\/JAD-160067.","journal-title":"J Alzheimers Dis"},{"key":"677_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.dadm.2017.03.004","volume":"8","author":"JP Cunha","year":"2017","unstructured":"Cunha JP, Proen\u00e7a R, Dias-Santos A, et al. Choroidal thinning: Alzheimer\u2019s disease and aging. Alzheimers Dement (Amst). 2017;8:11\u20137. Published 2017 Mar 30. https:\/\/doi.org\/10.1016\/j.dadm.2017.03.004.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"2","key":"677_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/WAD.0000000000000176","volume":"31","author":"A Trebbastoni","year":"2017","unstructured":"Trebbastoni A, Marcelli M, Mallone F, et al. Attenuation of choroidal thickness in patients with Alzheimer disease: evidence from an Italian prospective study. Alzheimer Dis Assoc Disord. 2017;31(2):128\u201334 0.1097\/WAD.0000000000000176.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"677_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/ceo.12386","volume":"43","author":"HA Bayhan","year":"2015","unstructured":"Bayhan HA, Aslan Bayhan S, Celikbilek A, Tan\u0131k N, G\u00fcrdal C. Evaluation of the chorioretinal thickness changes in Alzheimer\u2019s disease using spectral-domain optical coherence tomography. Clin Exp Ophthalmol. 2015;43(2):145\u201351. https:\/\/doi.org\/10.1111\/ceo.12386.","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"677_CR38","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3233\/JAD-132039","volume":"40","author":"M Gharbiya","year":"2014","unstructured":"Gharbiya M, Trebbastoni A, Parisi F, et al. Choroidal thinning as a new finding in Alzheimer\u2019s disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. J Alzheimers Dis. 2014;40(4):907\u201317. https:\/\/doi.org\/10.3233\/JAD-132039.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"677_CR39","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamaophthalmol.2018.3556","volume":"136","author":"BE O\u2019Bryhim","year":"2018","unstructured":"O\u2019Bryhim BE, Apte RS, Kung N, Coble D, Van Stavern GP. Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 2018;136(11):1242\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.3556.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"677_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41598-018-37271-6","volume":"9","author":"G Querques","year":"2019","unstructured":"Querques G, Borrelli E, Sacconi R, et al. Functional and morphological changes of the retinal vessels in Alzheimer\u2019s disease and mild cognitive impairment. Sci Rep. 2019;9(1):63. Published 2019 Jan 11. https:\/\/doi.org\/10.1038\/s41598-018-37271-6.","journal-title":"Sci Rep"},{"issue":"4","key":"677_CR41","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3233\/JAD-180738","volume":"66","author":"L Lahme","year":"2018","unstructured":"Lahme L, Esser EL, Mihailovic N, et al. Evaluation of ocular perfustion in Alzheimer\u2019s disease using optical coherence tomography angiography. J Alzheimers Dis. 2018;66(4):1745\u201352. https:\/\/doi.org\/10.3233\/JAD-180738.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"677_CR42","doi-asserted-by":"publisher","first-page":"e0214685","DOI":"10.1371\/journal.pone.0214685","volume":"14","author":"YS Zhang","year":"2019","unstructured":"Zhang YS, Zhou N, Knoll BM, et al. Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer\u2019s disease on optical coherence tomography angiography. PLoS One. 2019;14(4):e0214685. https:\/\/doi.org\/10.1371\/journal.pone.0214685.","journal-title":"PLoS One"},{"issue":"8","key":"677_CR43","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00347-019-0883-5","volume":"116","author":"CY Mardin","year":"2019","unstructured":"Mardin CY, Hosari S. Optical coherence tomography angiography in neuronal diseases: preliminary findings. Ophthalmologe. 2019;116(8):714\u201321. https:\/\/doi.org\/10.1007\/s00347-019-0883-5.","journal-title":"Ophthalmologe"},{"issue":"2","key":"677_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/bjophthalmol-2019-314127","volume":"104","author":"JA van de Kreeke","year":"2020","unstructured":"van de Kreeke JA, Nguyen HT, Konijnenberg E, et al. Optical coherence tomography angiography in preclinical Alzheimer\u2019s disease. Br J Ophthalmol. 2020;104(2):157\u201361. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314127.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"677_CR45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.oret.2019.02.002","volume":"3","author":"SP Yoon","year":"2019","unstructured":"Yoon SP, Grewal DS, Thompson AC, et al. Retinal microvascular and neurodegenerative changes in Alzheimer\u2019s disease and mild cognitive impairment compared with control participants. Ophthalmol Retina. 2019;3(6):489\u201399. https:\/\/doi.org\/10.1016\/j.oret.2019.02.002.","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"677_CR46","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1167\/iovs.19-27028","volume":"60","author":"P Zabel","year":"2019","unstructured":"Zabel P, Kaluzny JJ, Wilkosc-Debczynska M, et al. Comparison of retinal microvasculature in patients with Alzheimer\u2019s disease and primary open-angle glaucoma by optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2019;60(10):3447\u201355. https:\/\/doi.org\/10.1167\/iovs.19-27028.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"677_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3928\/23258160-20190503-02","volume":"50","author":"DS Grewal","year":"2019","unstructured":"Grewal DS, Fine HF, Fekrat S. Is OCT angiography useful in neurodegenerative diseases? Ophthalmic Surg Lasers Imaging Retina. 2019;50(5):269\u201373. https:\/\/doi.org\/10.3928\/23258160-20190503-02.","journal-title":"Ophthalmic Surg Lasers Imaging Retina."},{"issue":"6","key":"677_CR48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3928\/23258160-20180601-09","volume":"49","author":"DS Grewal","year":"2018","unstructured":"Grewal DS, Polascik BW, Hoffmeyer GC, Fekrat S. Assessment of differences in retinal microvasculature using OCT angiography in Alzheimer\u2019s disease: a twin discordance report. Ophthalmic Surg Lasers Imaging Retina. 2018;49(6):440\u20134. https:\/\/doi.org\/10.3928\/23258160-20180601-09.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"11","key":"677_CR49","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3928\/23258160-20191031-06","volume":"50","author":"SP Yoon","year":"2019","unstructured":"Yoon SP, Thompson AC, Polascik BW, et al. Correlation of OCTA and volumetric MRI in mild cognitive impairment and Alzheimer\u2019s disease. Ophthalmic Surg Lasers Imaging Retina. 2019;50(11):709\u201318. https:\/\/doi.org\/10.3928\/23258160-20191031-06.","journal-title":"Ophthalmic Surg Lasers Imaging Retina."},{"key":"677_CR50","doi-asserted-by":"publisher","unstructured":"Lee CS, Apte RS. Retinal biomarkers of Alzheimer\u2019s disease. Am J Ophthalmol. 2020 S0002-9394(20)30226-9. doi: https:\/\/doi.org\/10.1016\/j.ajo.2020.04.040.","DOI":"10.1016\/j.ajo.2020.04.040"},{"key":"677_CR51","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr","year":"2016","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer\u2019s disease biomarkers. Neurology. 2016;87:539\u201347.","journal-title":"Neurology"},{"issue":"s1","key":"677_CR52","doi-asserted-by":"publisher","first-page":"S271","DOI":"10.3233\/JAD-179926","volume":"64","author":"H Zetterberg","year":"2018","unstructured":"Zetterberg H, Blennow K. From cerebrospinal fluid to blood: the third wave of fluid biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis. 2018;64(s1):S271\u20139. https:\/\/doi.org\/10.3233\/JAD-179926.","journal-title":"J Alzheimers Dis"},{"key":"677_CR53","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V, et al. High-precision plasma beta-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology. 2019;93:e1647\u2013e59.","journal-title":"Neurology."},{"key":"677_CR54","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19:422\u201333.","journal-title":"Lancet Neurol"},{"key":"677_CR55","doi-asserted-by":"publisher","first-page":"Article no. 3","DOI":"10.1186\/s13195-017-0331-1","volume":"10","author":"S Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh S, Capellari S, Stanzani-Maserati M, et al. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alz Res Therapy. 2018;10:Article no. 3. https:\/\/doi.org\/10.1186\/s13195-017-0331-1.","journal-title":"Alz Res Therapy"},{"issue":"17","key":"677_CR56","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.18632\/aging.102220","volume":"11","author":"H Hu","year":"2019","unstructured":"Hu H, Chen KL, Ou YN, et al. Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults. Aging (Albany NY). 2019;11(17):6904\u201314. https:\/\/doi.org\/10.18632\/aging.102220.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"677_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-018-0404-9","volume":"10","author":"P Lewczuk","year":"2018","unstructured":"Lewczuk P, Ermann N, Andreasson U, et al. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease. Alzheimers Res Ther. 2018;10(1):71. Published 2018 Jul 28. https:\/\/doi.org\/10.1186\/s13195-018-0404-9.","journal-title":"Alzheimers Res Ther"},{"key":"677_CR58","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnagi.2019.00254","volume":"11","author":"M Jin","year":"2019","unstructured":"Jin M, Cao L, Dai YP. Role of neurofilament light chain as a potential biomarker for Alzheimer\u2019s disease: a correlative meta-analysis. Front Aging Neurosci. 2019;11:254. Published 2019 Sep 13. https:\/\/doi.org\/10.3389\/fnagi.2019.00254.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"677_CR59","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jalz.2017.11.015","volume":"14","author":"H Hampel","year":"2018","unstructured":"Hampel H, Toschi N, Baldacci F, Alzheimer Precision Medicine Initiative (APMI), et al. Alzheimer\u2019s disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: A\u03b21-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40. Alzheimers Dement. 2018;14(4):492\u2013501. https:\/\/doi.org\/10.1016\/j.jalz.2017.11.015.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"677_CR60","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.15252\/emmm.201606540","volume":"8","author":"N Mattsson","year":"2016","unstructured":"Mattsson N, Insel PS, Palmqvist S, et al. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer\u2019s disease. EMBO Mol Med. 2016;8(10):1184\u201396. Published 2016 Oct 4. https:\/\/doi.org\/10.15252\/emmm.201606540.","journal-title":"EMBO Mol Med"},{"issue":"10","key":"677_CR61","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00018-019-03040-5","volume":"76","author":"K Dhiman","year":"2019","unstructured":"Dhiman K, Blennow K, Zetterberg H, Martins RN, Gupta VB. Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer\u2019s disease pathogenesis. Cell Mol Life Sci. 2019;76(10):1833\u201363. https:\/\/doi.org\/10.1007\/s00018-019-03040-5.","journal-title":"Cell Mol Life Sci"},{"key":"677_CR62","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.neuint.2017.05.010","volume":"108","author":"S Lista","year":"2017","unstructured":"Lista S, Toschi N, Baldacci F, et al. Diagnostic accuracy of SCF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer\u2019s disease. Neurochem Int. 2017;108:355\u201360. https:\/\/doi.org\/10.1016\/j.neuint.2017.05.010.","journal-title":"Neurochem Int"},{"issue":"1\u20132","key":"677_CR63","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0006-8993(02)04052-0","volume":"963","author":"G Chidlow","year":"2003","unstructured":"Chidlow G, Osborne NN. Rat retinal ganglion cell loss caused by kainate, NMDA and ischemia correlates with a reduction in mRNA and protein of Thy-1 and neurofilament light. Brain Res. 2003;963(1\u20132):298\u2013306. https:\/\/doi.org\/10.1016\/S0006-8993(02)04052-0.","journal-title":"Brain Res"},{"key":"677_CR64","doi-asserted-by":"publisher","unstructured":"Taniguchi T, Shimazawa M, Hara H. Alterations in neurofilament light in optic nerve in rat kainate and monkey ocular hypertension models. Brain Res. 2004;(2):1013, 241\u20138. https:\/\/doi.org\/10.1016\/S0006-8993(02)04052-0.","DOI":"10.1016\/S0006-8993(02)04052-0"},{"issue":"3","key":"677_CR65","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.exer.2006.03.007","volume":"83","author":"M Sasaoka","year":"2006","unstructured":"Sasaoka M, Taniguchi T, Shimazawa M, Ishida N, Shimazaki A, Hara H. Intravitreal injection of endothelin-1 caused optic nerve damage following to ocular hypoperfusion in rabbits. Exp Eye Res. 2006;83(3):629\u201337. https:\/\/doi.org\/10.1016\/j.exer.2006.03.007.","journal-title":"Exp Eye Res"},{"issue":"6","key":"677_CR66","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1167\/iovs.09-4692","volume":"51","author":"C Balaratnasingam","year":"2010","unstructured":"Balaratnasingam C, Morgan WH, Bass L, Kang M, Cringle SJ, Yu DY. Time-dependent effects of focal retinal ischemia on axonal cytoskeleton proteins. Invest Ophthalmol Vis Sci. 2010;51(6):3019\u201328. https:\/\/doi.org\/10.1167\/iovs.09-4692.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"677_CR67","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000313985","volume":"45","author":"TA Kamalden","year":"2011","unstructured":"Kamalden TA, Ji D, Fawcett RJ, Osborne NN. Genistein blunts the negative effect of ischaemia to the retina caused by an elevation of intraocular pressure. Ophthalmic Res. 2011;45(2):65\u201372. https:\/\/doi.org\/10.1159\/000313985.","journal-title":"Ophthalmic Res"},{"issue":"5","key":"677_CR68","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1177\/1352458515599074","volume":"22","author":"S Modvig","year":"2016","unstructured":"Modvig S, Degn M, Sander B, et al. Cerebrospinal fluid neurofilament light chain levels predict visual outcomes after optic neuritis. Mult Scler. 2016 Apr;22(5):590\u20138. https:\/\/doi.org\/10.1177\/1352458515599074.","journal-title":"Mult Scler"},{"issue":"2","key":"677_CR69","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/157015908784533851","volume":"6","author":"KG Schmidt","year":"2008","unstructured":"Schmidt KG, Bergert H, Funk RH. Neurodegenerative diseases of the retina and potential for protection and recovery. Curr Neuropharmacol. 2008;6(2):164\u201378. https:\/\/doi.org\/10.2174\/157015908784533851.","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"677_CR70","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3233\/JAD-2010-100210","volume":"20","author":"A Prakasam","year":"2010","unstructured":"Prakasam A, Muthuswamy A, Ablonczy Z, et al. Differential accumulation of secreted A\u03b2PP metabolites in ocular fluids. J Alzheimers Dis. 2010;20(4):1243\u201353. https:\/\/doi.org\/10.3233\/JAD-2010-100210.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"677_CR71","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1021\/cn500242z","volume":"6","author":"S More Swati","year":"2015","unstructured":"More Swati S, Robert V. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer\u2019s mouse retina well before onset of cognitive decline. ACS Chem Neurosci. 2015;6(2):306\u201315. https:\/\/doi.org\/10.1021\/cn500242z.","journal-title":"ACS Chem Neurosci"},{"key":"677_CR72","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-016-0054-4","volume":"5","author":"C Zheng","year":"2016","unstructured":"Zheng C, Zhou XW, Wang JZ. The dual roles of cytokines in Alzheimer\u2019s disease: update on interleukins, TNF-\u03b1, TGF-\u03b2 and IFN-\u03b3. Transl Neurodegener. 2016;5:7. https:\/\/doi.org\/10.1186\/s40035-016-0054-4.","journal-title":"Transl Neurodegener"},{"key":"677_CR73","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Hu Y, Cao Z, Liu Q, Cheng Y. Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer\u2019s disease, Parkinson\u2019s disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front Immunol. 2018;9:2122. https:\/\/doi.org\/10.3389\/fimmu.2018.02122.","journal-title":"Front Immunol"},{"key":"677_CR74","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fneur.2018.00726","volume":"9","author":"DW Li","year":"2018","unstructured":"Li DW, Ren H, Jeromin A, et al. Diagnostic performance of neurofilaments in Chinese patients with amyotrophic lateral sclerosis: a prospective study. Front Neurol. 2018;9:726. https:\/\/doi.org\/10.3389\/fneur.2018.00726.","journal-title":"Front Neurol"},{"issue":"1","key":"677_CR75","doi-asserted-by":"publisher","first-page":"e30525","DOI":"10.1371\/journal.pone.0030525","volume":"7","author":"K Westin","year":"2012","unstructured":"Westin K, Buchhave P, Nielsen H, Minthon L, Janciauskiene S, Hansson O. CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer\u2019s disease. PLoS One. 2012;7(1):e30525. https:\/\/doi.org\/10.1371\/journal.pone.0030525.","journal-title":"PLoS One"},{"issue":"4","key":"677_CR76","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3233\/JAD-2007-11405","volume":"11","author":"D Tripathy","year":"2007","unstructured":"Tripathy D, Thirumangalakudi L, Grammas P. Expression of macrophage inflammatory protein 1-\u03b1 is elevated in Alzheimer\u2019s vessels and regulated by oxidative stress. J Alzheimer\u2019s Dis. 2007;11(4):447\u201355. https:\/\/doi.org\/10.3233\/JAD-2007-11405.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"677_CR77","doi-asserted-by":"publisher","unstructured":"Kim H, Shin A, Lee KJ. Differences in C-reactive protein level in patients with Alzheimer\u2019s disease and mild cognitive impairment. J Psychiatry. 2015;18(1):Psychiatry-14-Psychiatry155. doi: 18:1.https:\/\/doi.org\/10.4172\/1994-8220.1000194.","DOI":"10.4172\/1994-8220.1000194"},{"issue":"11","key":"677_CR78","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.3390\/ijms20112812","volume":"20","author":"V Cipollini","year":"2019","unstructured":"Cipollini V, Troili F, Giubilei F. Emerging biomarkers in vascular cognitive impairment and dementia: from pathophysiological pathways to clinical application. Int J Mol Sci. 2019;20(11):2812. https:\/\/doi.org\/10.3390\/ijms20112812.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"677_CR79","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/BEN-1993-6405","volume":"6","author":"L Sabe","year":"1993","unstructured":"Sabe L, Jason L, Juejati M, Leiguarda R, Starkstein S. Sensitivity and specificity of the Mini-Mental State Exam in the diagnosis of dementia. Behav Neurol. 1993;6(4):207\u201310. https:\/\/doi.org\/10.3233\/BEN-1993-6405.","journal-title":"Behav Neurol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00677-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00677-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00677-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T23:11:30Z","timestamp":1668813090000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00677-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["677"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00677-4","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval and oversight for the study protocol were provided by the BUMC Institutional Review Board and was in accordance with the ethical standards of the Committee on Human Experimentation of our institution and the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Henrik Zetterberg (HZ) has served at the scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, and CogRx; has given lectures in symposia sponsored by Fujirebio, Alzecure, and Biogen; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. Kaj Blennow has served as a consultant at the advisory boards or at the data monitoring committees for Abcam, Axon, Biogen, Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. The other authors have no conflict of interest to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}